A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Atopic Dermatitis
In brief
The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).
Key facts
- Study ID
- NCT03831191
- Run by
- Eli Lilly and Company
- People needed
- 136
- Starts
- 2019-02-12
- Expected to finish
- 2020-02-27
- Last updated by the study team
- 2021-04-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants must have diagnosis of AD >= 12 months according to the American Academy of Dermatology criteria.
- Participants must have moderate to severe AD at screening and randomization.
- Participants must have inadequate response to topical medications within 6 months of screening (or history of intolerance).
You may not qualify if…
- Participants must not have concurrent treatment with topical or systemic treatments for AD.
Where it is running
- Dermatology Research Associates — Los Angeles, California, United States
- Quest Dermatology Research — Northridge, California, United States
- Integrative Skin Science and Research — Sacramento, California, United States
- Arlington Dermatology — Rolling Meadows, Illinois, United States
- The South Bend Clinic — South Bend, Indiana, United States
- Dermatology and Skin Cancer Specialists — Rockville, Maryland, United States
- ActivMed Practices & Research, Inc — Portsmouth, New Hampshire, United States
- Piedmont Plastic Surgery and Dermatology — Charlotte, North Carolina, United States
- PMG Research of Wilmington, LLC — Wilmington, North Carolina, United States
- Hightower Clinical Trial Services — Norman, Oklahoma, United States
- Oregon Dermatology and Research Center — Portland, Oregon, United States
- Clinical Partners LLC — Johnston, Rhode Island, United States
- Center for Clinical Studies — Houston, Texas, United States
- DOM- Centro de Reumatologia — CABA, Buenos Aires, Argentina
- Centro de Investigaciones Metabólicas (CINME) — Buenos Aires, Argentina
- Buenos Aires Skin — Ciudad Autonoma Buenos Aires, Argentina
- Instituto de Neumonología y Dermatología — Ciudad Autonoma Buenos Aires, Argentina
- Psoriahue Medicina Interdisciplinaria — Ciudad Autonoma Buenos Aires, Argentina
- Parra Dermatología — Mendoza, Argentina
- Centro Medico Privado de Reumatologia — San Miguel de Tucumán, Argentina
- Universitätsklinikum Graz — Graz, Styria, Austria
- LKH Feldkirch — Feldkirch, Vorarlberg, Austria
- Sozialmed. Zentrum Ost - Donauspital — Vienna, Austria
- The Guenther Dermatology Research Centre — London, Ontario, Canada
- Tien Q. Nguyen, MD inc. DBA First OC Dermatology — Fountain Valley, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.